SPRB
Spruce Biosciences (SPRB)
$32
About Spruce Biosciences (SPRB)
Spruce Biosciences, Inc. is a late-stage biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. It focuses on developing its wholly owned product candidate, Tildacerfont. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.
Details
Daily high
$0.33
Daily low
$0.30
Price at open
$0.32
52 Week High
$0.87
52 Week Low
$0.30
Market cap
13.2M
Dividend yield
0.00%
Volume
110,547
Avg. volume
185,188
P/E ratio
-.33
Spruce Biosciences News
Details
Daily high
$0.33
Daily low
$0.30
Price at open
$0.32
52 Week High
$0.87
52 Week Low
$0.30
Market cap
13.2M
Dividend yield
0.00%
Volume
110,547
Avg. volume
185,188
P/E ratio
-.33